IQVIA’s Post

Last chance to register for our Virtual Conference June 26-27, which explores Innovation in RWE and Medical Affairs. Join IQVIA and industry experts for sessions discussing the value and evolving uses of #RWE, regulatory guidance, and how innovation and technology can help drive efficiencies in programs to generate fit-for-purpose RWE. https://bit.ly/3KUwPeP

Is Medical Affairs the Hidden Powerhouse of Biopharma? 5 Compelling Reasons It's Shaping the Future In an era where trust in pharma is under scrutiny, could Medical Affairs be the key to transformation? Here's why I believe it's time to put Medical Affairs in the driver's seat: Trust Builders: Bridging science and clinical practice, rebuilding industry credibility. RWE Revolutionaries: Leveraging real-world evidence to improve patient outcomes. Patient Voice Amplifiers: Putting patients at the center. Cross-Functional Maestros: Breaking silos, driving innovation. MA-led collaborations have accelerated personalized therapy development. Ethical Compass: Upholding standards even under pressure. Is it time we recognize the strategic value of Medical Affairs? What's your experience? #MedicalAffairs #Biopharma #HealthcareInnovation #PatientCentricity

New Article and Video Tutorial Strategic Thinking in Medical Affairs: Approaches and Frameworks https://buff.ly/4dRLFj6 #StrategicThinking

Your #pharma team can move faster when you have better insights. Learn how a medical director got higher-quality input from a group of global, multi-disciplinary experts. https://hubs.la/Q02zKv6k0

Designing Patient-Centric Trials on a Budget: A Quantitative Framework, Upcoming Webinar Hosted by Xtalks — PRBuzz.co — #pin this #free #webinar attendees will #gain insights into strategies for optimizing the allocation of #limited resources to maximize the #impact of clinical #trials The #featured #speakers will discuss a #study #design and authoring #solution that can #help in ensuring an #effective and patient-centric #trial design. This includes strategies for optimizing the allocation of limited resources to maximize the impact of your clinical trial; techniques to identify and mitigate risks associated with #financial constraints; and #crafting trials that can adapt to financial #challenges while maintaining scientific rigor. TORONTO, May #1 #2024 #Sponsors and study #teams must navigate considerable uncertainty to ensure #safety and efficacy endpoints #meet the approval of #health authorities, regulatory agencies and payers. They must achieve this while also ensuring studies are patient-centric and that key risks are mitigated while collecting complete data to support approval. Regulatory guidance from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use

Learn how to optimize your trials with advice from global clinical research experts! Introducing Clinical Confidential, a new document series from MCRA’s Global Clinical Research Organization. In this series, we’ll reveal the interrelated requirements of clients developing novel healthcare technologies from a global perspective. Led by a team of industry experts and informed by the entire commercialization process, the series will help guide established companies and startups through the clinical trial labyrinth with the goal of maximizing the value of their healthcare innovations. #MCRA #clinicalresearch #medtech #medicaldevice #regulatory #machinelearning #FDAsubmission #digitalhealth Contact Us https://lnkd.in/egTEWYaV

Unlock the secrets to optimizing clinical trials with our latest blog on the vital role of linguistic validation. 🌐💉 Whether you're involved in clinical research, regulatory affairs, or patient recruitment, this blog offers valuable insights to enhance your trial's success. 👉 Dive into the full blog now: https://lnkd.in/gS__HPqy #ClinicalTrials #LinguisticValidation #Research #Healthcare #LifeSciences #Morningside #Questel

Learn how to optimize your trials with advice from global clinical research experts. Introducing Clinical Confidential, a new document series from MCRA’s Global Clinical Research Organization. In this series, we’ll reveal the interrelated requirements of clients developing novel healthcare technologies from a global perspective. Led by a team of industry experts and informed by the entire commercialization process, the series will help guide established companies and startups through the clinical trial labyrinth with the goal of maximizing the value of their healthcare innovations.   Contact Us https://lnkd.in/eEXumAgX   #MCRA #clinicalresearch #medtech #medicaldevice #regulatory #machinelearning #FDAsubmission #digitalhealth

Designing Patient-Centric Trials on a Budget: A Quantitative Framework, Upcoming Webinar Hosted by Xtalks — MediaContacts.co — #pin this #free #webinar attendees will #gain insights into strategies for optimizing the allocation of #limited resources to maximize the #impact of clinical #trials The #featured #speakers will discuss a #study #design and authoring #solution that can #help in ensuring an #effective and patient-centric #trial design. This includes strategies for optimizing the allocation of limited resources to maximize the impact of your clinical trial; techniques to identify and mitigate risks associated with #financial constraints; and #crafting trials that can adapt to financial #challenges while maintaining scientific rigor. TORONTO, May #1 #2024 #Sponsors and study #teams must navigate considerable uncertainty to ensure #safety and efficacy endpoints #meet the approval of #health authorities, regulatory agencies and payers. They must achieve this while also ensuring studies are patient-centric and that key risks are mitigated while collecting complete data to support approval. Regulatory guidance from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use

Imagine transforming your Medical Excellence group from good to exceptional. Don’t let your strategy fall behind. Our benchmarking research, involving insights from 57 Medical leaders, reveals that success in Medical Excellence is relationship driven, staff must build trust and rapport with internal stakeholders. It is critical not to be perceived as “owning” or “dictating” excellence, but rather to listen to fellow teams, identify best practices, and pass credit along. Download our free summary to learn more about building effective Medical Excellence teams: https://lnkd.in/dnhAmUqE #MedicalAffairs #MedicalExcellence #MedAffairs #Pharma #MedicalDevices #BestPractices